KATELYN FINLEY: Open Payments
NPI 1922597384 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$75 in 3 payments from 3 companies in 2025. Trend: 2023 $210 · 2024 $306 · 2025 $75
Food & beverage: $75
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 1 | $27 |
| IMMUNITYBIO, INC. | 1 | $26 |
| Boston Scientific Corporation | 1 | $22 |
Products named: GEMTESA, ANKTIVA, Rezum Generator.
Industry payments across IA — which companies pay providers there.
